Scarica l'app Stockscreener
1.04
1.96%
0.02
Precedente Chiudi:
$1.02
Aprire:
$0.99
Volume 24 ore:
176.58K
Relative Volume:
0.40
Capitalizzazione di mercato:
$116.15M
Reddito:
-
Utile/perdita netta:
$-21.65M
Rapporto P/E:
-3.1316
EPS:
-0.3321
Flusso di cassa netto:
$-15.84M
1 W Prestazione:
+4.54%
1M Prestazione:
+6.95%
6M Prestazione:
-6.31%
1 anno Prestazione:
-16.13%
Intervallo 1D:
$0.9801
$1.0599
Intervallo di 1 settimana:
$0.9801
$1.10
Portata 52W:
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.04 | 113.91M | 0 | -21.65M | -15.84M | -0.3321 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-06-26 | Iniziato | ROTH MKM | Buy |
| 2024-04-22 | Iniziato | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Borsa (CRDL) Ultime notizie
Cardiol Therapeutics announces $13.5M bought-deal private placement - MSN
Aug Drivers: Is Cardiol Therapeutics Inc stock risky to hold nowRecession Risk & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Why Cardiol Therapeutics Inc. stock remains resilientWeekly Investment Summary & AI Driven Stock Price Forecasts - mfd.ru
Is Cardiol Therapeutics Inc. a momentum stockWeekly Profit Report & Safe Capital Growth Plans - mfd.ru
(CRDL) Financial Trading Report (CRDL:CA) - Stock Traders Daily
Fundamentals Check: Can Cardiol Therapeutics Inc maintain its current growth rateJobs Report & Expert Approved Momentum Ideas - baoquankhu1.vn
Can Cardiol Therapeutics Inc generate free cash flow2025 Price Action Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
CRDL Stock Rating Reiterated at 'Buy' by HC Wainwright & Co. | C - GuruFocus
Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright - MarketBeat
Cardiol Therapeutics Inc. - Baystreet.ca
Cardiol Therapeutics publishes phase II myocarditis study results - Investing.com
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure - TipRanks
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - Investing News Network
Cardiol Therapeutics publishes phase II myocarditis study results By Investing.com - Investing.com India
How the (CRDL) price action is used to our Advantage (CRDL:CA) - Stock Traders Daily
Equities Analysts Set Expectations for CRDL FY2025 Earnings - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Stock Rating Upgraded by Brookline Cap M - MarketBeat
Analysts Offer Predictions for CRDL FY2025 Earnings - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% – Time to Sell? - Defense World
Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1%Time to Sell? - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Upgraded at Brookline Capital Management - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Raised to Strong-Buy at Brookline Capital Management - MarketBeat
(CRDL) Market Dynamics and Trading Signals (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics files underwriting agreement and warrant indenture By Investing.com - Investing.com Nigeria
Cardiol Therapeutics files underwriting agreement and warrant indenture - Investing.com
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing - TipRanks
Targets Report: Can Cardiol Therapeutics Inc weather a recessionPortfolio Profit Report & Daily Growth Stock Tips - baoquankhu1.vn
Fund Flows: Will Ambarella Inc stock benefit from M A2025 Trading Volume Trends & Safe Swing Trade Setups - baoquankhu1.vn
Aug Retail: Is MPWR in a bullish channel2025 Volatility Report & Daily Entry Point Trade Alerts - baoquankhu1.vn
(CRDL) Strategic Equity Report (CRDL:CA) - Stock Traders Daily
Can Cardiol Therapeutics Inc. weather a recessionJuly 2025 Analyst Calls & Verified Technical Trade Signals - mfd.ru
Cardiol Therapeutics Secures U.S. Patent for Heart Drugs - MSN
Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs - TipRanks
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Investing News Network
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Investing News Network
When the Price of (CRDL) Talks, People Listen (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million - TMX Newsfile
Cardiol Therapeutics Inc. announced that it has received CAD 13.500001 million in funding - marketscreener.com
(CRDL) Equity Trading Insights (CRDL:CA) - Stock Traders Daily
Top Canadian Stocks to Buy Right Away With $5,000 - Yahoo! Finance Canada
Will Cardiol Therapeutics Inc. (CT9) stock gain from lower interest ratesChart Pattern Recognition & Free Discover Fast Growing Stocks - bollywoodhelpline.com
Why Cardiol Therapeutics Inc. stock is favored by top institutionsCup and Handle Formations & Identify Breakout Stocks - bollywoodhelpline.com
Portfolio Shifts: Will Cardiol Therapeutics Inc outperform tech stocksTake Profit & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Cardiol Therapeutics announces $13.5 million private placement By Investing.com - Investing.com Nigeria
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics announces $13.5 million bought deal financing By Investing.com - Investing.com Nigeria
Cardiol Therapeutics Inc. announced that it expects to receive CAD 13.500001 million in funding - marketscreener.com
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs - TipRanks
Cardiol Therapeutics announces $13.5 million private placement - Investing.com
Cardiol Therapeutics announces $13.5 million bought deal financing - Investing.com
Heart drug developer Cardiol lines up $13.5M to fund trials and research - Stock Titan
Cardiol Therapeutics Inc Azioni (CRDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):